NEW YORK, March 22, 2017 /PRNewswire/ --
Pre-market today, Stock-Callers.com has initiated research reports on these four stocks: The Procter & Gamble Co. (NYSE: PG), Coty Inc. (NYSE: COTY), Avon Products Inc. (NYSE: AVP), and Colgate-Palmolive Co. (NYSE: CL). These companies belong to the Personal Products industry - a massive field that creates, manufactures and sells beauty, hygiene and personal-care products like cosmetics, toothpastes, sunscreen, razors and shaving cream. Learn more about these stocks by downloading their free research reports in PDF format at:
Procter & Gamble
On Tuesday, shares in Cincinnati, Ohio-based The Procter & Gamble Co. recorded a trading volume of 8.21 million shares. The stock ended the day at $91.19, declining 0.03% from the last trading session. The Company's shares have advanced 0.11% in the past month, 8.54% in the previous three months, and 9.32% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 3.07% and 6.77%, respectively. Furthermore, shares of Procter & Gamble, which provides branded consumer packaged goods to consumers in North America, Europe, Asia/Pacific, India, Middle East, Africa, and Latin America, have a Relative Strength Index (RSI) of 58.29.
On March 21st, 2017, research firm JP Morgan initiated a 'Neutral' rating on the Company's stock, with a target price of $98 per share. Sign up and read the free research report on PG at:
New York headquartered Coty's stock saw a drop of 3.24%, finishing yesterday's session at $18.53. A total volume of 7.02 million shares was traded, which was above their three months average volume of 5.54 million shares. The Company's shares have gained 1.88% since the start of this year. The stock is trading below its 50-day moving average by 2.06%. Additionally, shares of Coty, which together with its subsidiaries, manufactures, markets, and distributes beauty products worldwide, have an RSI of 44.38.
On March 07th, 2017, Coty announced that Esi Eggleston Bracey, President Coty Consumer Beauty, has decided to leave the Company for personal reasons. Esi will remain with Coty for a transition period through the end of March. Laurent Kleitman, currently Unilever's Executive Vice President Global Hair Care category, has been appointed President Coty's Consumer Beauty. Laurent will report directly to Camillo Pane, Coty's CEO, and will be a member of Coty's Executive Committee.
On March 21st, 2017, research firm JP Morgan initiated an 'Underweight' rating on the Company's stock, with a target price of $16 per share. The complimentary research report on COTY can be downloaded at:
Shares in London, the UK headquartered Avon Products Inc. ended the session 1.59% lower at $4.33. The stock recorded a trading volume of 8.53 million shares, which was above its three months average volume of 5.81 million shares. The Company's shares are trading 14.91% below their 50-day moving average. Moreover, shares of Avon Products, which manufactures and markets beauty and related products in Europe, Middle East, Africa, South Latin America, North Latin America, and Asia/Pacific, have an RSI of 38.64.
On March 20th, 2017, Avon Products announced that Jeff Benjamin, Senior Vice President General Counsel & Chief Ethics & Compliance Officer has decided to retire from the Company. Mr. Benjamin joined Avon in 2012, and will remain in his current position until a successor is named. Avon will be hiring a General Counsel, who will be based in the Company's global headquarters in the UK. Register for free on Stock-Callers.com and access the latest report on AVP at:
At the closing bell on Tuesday, New York headquartered Colgate-Palmolive Co.'s stock dropped 0.14%, finishing at $73.70. A total volume of 3.70 million shares was traded. The Company's shares have gained 2.39% in the last month, 11.92% over the previous three months, and 13.27% on an YTD basis. The stock is trading 6.01% and 4.92% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Colgate-Palmolive, which together with its subsidiaries, manufactures and sells consumer products worldwide, have an RSI of 60.87.
On March 10th, 2017, Colgate-Palmolive's Board of Directors increased the quarterly common stock cash dividend by 3%. The increase will be effective in Q2 FY17. The new rate of $0.40 per share is up from $0.39 per share. The Board declared that Q2 dividend is to be paid on May 15th, 2017 to shareholders of record as of April 21st, 2017.
On March 21st, 2017, research firm JP Morgan initiated a 'Neutral' rating on the Company's stock, with a target price of $77 per share. Get free access to your research report on CL at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA